These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12656640)

  • 1. Drugs for increasing oxygen and their potential use in doping: a review.
    Gaudard A; Varlet-Marie E; Bressolle F; Audran M
    Sports Med; 2003; 33(3):187-212. PubMed ID: 12656640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new frontiers of blood doping].
    Lippi G; Franchini M
    Recenti Prog Med; 2002 Jan; 93(1):1-8. PubMed ID: 11850993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry, physiology, and complications of blood doping: facts and speculation.
    Lippi G; Franchini M; Salvagno GL; Guidi GC
    Crit Rev Clin Lab Sci; 2006; 43(4):349-91. PubMed ID: 16769597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial oxygen carriers--the new doping threat in endurance sport?
    Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H
    Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood boosting today].
    Audran M; Varlet-Marie E
    Bull Acad Natl Med; 2004; 188(6):945-53. PubMed ID: 15651424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemistry of drugs and doping methods used to enhance aerobic sport performance.
    Cooper CE
    Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood doping: 2].
    Cristani A; Boldrini E; Amateis E; Arioli D
    Recenti Prog Med; 2005 Jan; 96(1):1-3. PubMed ID: 15789630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood doping : infusions, erythropoietin and artificial blood.
    Eichner ER
    Sports Med; 2007; 37(4-5):389-91. PubMed ID: 17465616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
    Wilber RL
    Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid.
    Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ
    Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in the detection of recombinant human erythropoiesis and its analogs in doping control].
    Yang X; Pang N; Liao Y; Liu H
    Se Pu; 2008 Jul; 26(4):413-6. PubMed ID: 18959234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin.
    Jelkmann W
    J Endocrinol Invest; 2003 Sep; 26(9):832-7. PubMed ID: 14964434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping.
    Böning D; Maassen N; Pries A
    J Appl Physiol (1985); 2008 Dec; 105(6):1988; author reply 1989. PubMed ID: 19050342
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.
    Diamanti-Kandarakis E; Konstantinopoulos PA; Papailiou J; Kandarakis SA; Andreopoulos A; Sykiotis GP
    Sports Med; 2005; 35(10):831-40. PubMed ID: 16180943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.